Acurx Pharmaceuticals, Inc.
DNA Polymerase IIIC Inhibitors and Use Thereof
Last updated:
Abstract:
The present invention relates to compounds and methods useful for inhibiting the DNA polymerase IIIC enzyme. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of Gram-positive bacteria infections.
Status:
Application
Type:
Utility
Filling date:
2 Apr 2021
Issue date:
14 Apr 2022